Видео ютуба по тегу Medicines: Casdatifan

ARC-20: Casdatifan Plus Cabozantinib Expansion Cohort
ARC-20: Casdatifan Plus Cabozantinib Expansion Cohort
ARC-20: casdatifan monotherapy in pre-treated clear cell renal cell carcinoma
ARC-20: casdatifan monotherapy in pre-treated clear cell renal cell carcinoma
ASCOGU25: Toni Choueiri MD., on Casdatifan | Dana-Farber Cancer Institute
ASCOGU25: Toni Choueiri MD., on Casdatifan | Dana-Farber Cancer Institute
ARC-20: Casdatifan for Patients With Previously Treated ccRCC
ARC-20: Casdatifan for Patients With Previously Treated ccRCC
Toni Choueiri on casdatifan in kidney cancer: ENA24 | Dana-Farber Cancer Institute
Toni Choueiri on casdatifan in kidney cancer: ENA24 | Dana-Farber Cancer Institute
New and upcoming treatments for clear cell renal cell carcinoma
New and upcoming treatments for clear cell renal cell carcinoma
2025 ASCO Kidney Cancer Highlights
2025 ASCO Kidney Cancer Highlights
KCRS24 - Biotech Showcase on Emerging Therapies for Kidney Cancer | KidneyCAN
KCRS24 - Biotech Showcase on Emerging Therapies for Kidney Cancer | KidneyCAN
Evaluating the evolving role of belzutifan in renal cell carcinoma
Evaluating the evolving role of belzutifan in renal cell carcinoma
BCG, Biomarkers, and Beyond: GU Oncology Research and Treatment Advances
BCG, Biomarkers, and Beyond: GU Oncology Research and Treatment Advances
Biotech Showcase | Kidney Cancer Research Summit 2025
Biotech Showcase | Kidney Cancer Research Summit 2025
ASCO25: Toni Choueiri, MD, ARC-20 Study | Dana-Farber Cancer Institute
ASCO25: Toni Choueiri, MD, ARC-20 Study | Dana-Farber Cancer Institute
EA8143/PROSPER RCC Clinical Trial for Renal Cell Carcinoma
EA8143/PROSPER RCC Clinical Trial for Renal Cell Carcinoma
2026 год определит будущее персонализированной медицины: 12 важных клинических исследований.
2026 год определит будущее персонализированной медицины: 12 важных клинических исследований.
Immunology Update – December 17, 2025: ITP win, CAR T in SLE, First RDEB gene therapy and More
Immunology Update – December 17, 2025: ITP win, CAR T in SLE, First RDEB gene therapy and More
Discover the Latest Genitourinary Cancer Updates
Discover the Latest Genitourinary Cancer Updates
RCC trials at ASCO 2025: CheckMate 214, ARC-20, LITESPARK-004 and TRAVERSE
RCC trials at ASCO 2025: CheckMate 214, ARC-20, LITESPARK-004 and TRAVERSE
Oral Abstract Presentations | Kidney Cancer Research Summit 2025
Oral Abstract Presentations | Kidney Cancer Research Summit 2025